biotech

Genomic Health, Inc. Announces Pricing of Initial Public Offering

Filed in archive Corporate and Industrial News , Genomics, Proteomics and Bioinformatics on September 29, 2005

BlogPicture

Genomic Health, Inc. announced the pricing of its initial public offering of 5,016,722 shares of its Common Stock at $12.00 per share.

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. Genomic Health's Oncotype DX� breast cancer Assay is alrady available for use to quantify the likelihood of breast cancer recurrence and predict benefit with certain types of chemotherapy for an individual patient.

Permalink: Genomic Health, Inc. Announces Pricing of Initial Public Offering

Tags: IPO  genomics  biotech  health  genomic  genomic+health  public+offering  initial+public 

Vote for Genomic Health, Inc. Announces Pricing of Initial Public Offering:

  • Currently 10.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 10.00 out of 1 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Tagcloud
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells